Wednesday 20/November/2024 – 11:04 PM
The Pharmaceuticals Division of the General Federation of Chambers of Commerce held An important meeting Today, Wednesday, in the presence of a large number of representatives of pharmaceutical companies and factories operating in Egypt, to discuss the challenges of the sector with the Medical Stamp Collection Authority of the Federation of Medical Professions.
Decisions from the Pharmaceuticals Division regarding its crisis with the medical stamp collection device
Dr. Ali Aouf, head of the division, confirmed to Cairo 24 that the meeting dealt with establishing clear mechanisms to deal with the challenges facing companies with the medical stamp collection device, in a way that ensures the continuity of production and supports the national pharmaceutical industry.
Ali Aouf added that these mechanisms included a commitment to implement the Medical Stamping Law in its correct form and not to pay any additional amounts not stipulated by law, stressing that the Medical Stamping Authority, as a private entity for the medical staff, does not have the right to review companies’ budgets and accounts without legal support.
The Pharmaceuticals Division of the General Federation of Chambers of Commerce confirmed the submission of an official request to the Egyptian Drug Authority to separate the medical stamp from the Authority’s transactions, as well as requesting the Consumer Protection Agency and the Central Auditing Organization to implement the principle of transparency by revealing medical stamp resources and expenses, in addition to clarifying the special commissions and incentives system. With the device.
As part of its escalatory steps, Dr. Ali Aouf pointed out that the Pharmaceuticals Division has addressed the Prime Minister to resolve the medical stamp crisis, which is disrupting the wheel of production.
The medical stamp is a financial sum imposed by the Council of the Federation of Medical Professions on certain transactions or documents related to medical fields, including medicines, and its proceeds are used to support the activities of the Federation of Medical Professions Unions and finance its various programs such as subsidies and pensions.
Comment by the Secretary of the Medical Professions Union on the Pharmaceutical Division’s crisis regarding stamp collection procedures
Earlier, Dr. Mohamed Alaa, Secretary-General of the Federation of Medical Professions Syndicates, commented on the criticism directed at the Federation’s medical stamp collection device, saying that the law and a previous decision of the Minister of Health and Population obligated pharmaceutical companies to pay a maximum of 50 piasters of the selling price according to the form mentioned in the decision. Pricing, whether it’s a bar or a package.
Muhammad Alaa explained to: Cairo 24If the pricing decision is issued for a strip, a maximum of 50 piasters will be collected from the price of one strip, not the entire package. However, if the pricing decision is issued for the package, the selling price of the entire package will be collected, regardless of the number of strips in it.
As for the continued collection of a stamp on the capital after licensing, he stressed that the law did not specify whether the collection was from the licensed or the issued capital, but we decided to collect from the licensor, and in some cases the collection is made from the issuer, which is less valuable than the licensor, with the establishment pledging to pay on Any increase that occurs to the issuer until it reaches the licensed value.
The Secretary-General of the Federation of Medical Professions Syndicates confirmed that reviewing the budget is a duty determined by law and obligating the Federation, based on Article No. 6 of Law Establishing the Federation No. 12 of 1983, which stipulated the establishment of a device to monitor compliance with collecting the medical stamp.
